2024
Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature. JAAD Case Rep. 2024;43:40-50.
Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses. JACC Cardiovasc Imaging. 2024;17(2):128-145.
Distinct mesenchymal cell states mediate prostate cancer progression. Nat Commun. 2024;15:363.
Skeletal stem cells in bone development, homeostasis and disease. Protein Cell. 2024.
Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence. J Clin Endocrinol Metab. 2024.
2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023;75(10):1687-1702.
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer. NPJ Precis Oncol. 2023;7(1):52.
Perineural Invasion in Papillary Thyroid Cancer: A Rare Indicator of Aggressive Disease. Ann Surg Oncol. 2023;30(6):3570-3577.